Dr Jan Petracek, PrimeVigilance CEO, has been invited to speak at the DIA CHINA ANNUAL MEETING 2018 held at the Beijing International Convention Center, China on May 22-25, 2018.

Dr Jan Petracek will be part of the Program Committee of the ICH Day Workshop: Pharmacovigilance and MedDRA, lecturing at two sessions focusing on ICH E2A and Practical Consideration on May 22. In addition to lecturing during the Pharmacovigilance & Safety sessions on Post Authorization Safety Studies and E2F Updates on Development Safety Update Reports on May 24th and 25th .

The 10th #DIA China Annual Meeting is a four-day conference which will bring together more than 2000 pharmaceutical R&D professionals from several continents and regions, involved in all levels of the healthcare product development spectrum, to discuss recent and upcoming transformational changes for China’s innovation and regulatory environments.

Program and registration details are available on the #DIAwebsite here.

If you would like to set up a meeting with Dr Petracek during this event or have any other questions, please let us know by contacting us directly at bd@primevigilance.com.

Share this: